Biography
Publications
2016
- Berthon, B.et al. 2016. ATLAAS: an automatic decision tree-based learning algorithm for advanced image segmentation in positron emission tomography. Physics in Medicine and Biology 61(13), pp. 4855-4869. (10.1088/0031-9155/61/13/4855)
- Sacco, J. J.et al. 2016. Systemic listeriosis following vaccination with the attenuatedListeria monocytogenestherapeutic vaccine, ADXS11-001. Human Vaccines & Immunotherapeutics 12(4), pp. 1085-1086. (10.1080/21645515.2015.1121338)
- Hendry, M.et al. 2016. Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations. BMJ Open 6(4), article number: e011205. (10.1136/bmjopen-2016-011205)
2015
- Owadally, W.et al. 2015. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer 15, article number: 602. (10.1186/s12885-015-1598-x)
- Powell, N. G. and Evans, M. 2015. Human papillomavirus-associated head and neck cancer: oncogenic mechanisms, epidemiology and clinical behaviour. Diagnostic Histopathology 21(2), pp. 49-64. (10.1016/j.mpdhp.2015.02.003)
2014
- Caley, A.et al. 2014. Multicentric human papillomavirus-associated head and neck squamous cell carcinoma. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck 37(2), pp. 202-208. (10.1002/hed.23584)
2013
- Al-Taei, S.et al. 2013. Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy. Cancer Immunology, Immunotherapy 62(12), pp. 1821-1830. (10.1007/s00262-013-1488-5)
- Evans, M.et al. 2013. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer 13(1), article number: 220. (10.1186/1471-2407-13-220)
2012
- Gwynne, S. H.et al. 2012. Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. International Journal of Radiation Oncology*Biology*Physics 84(4), pp. 1037-1042. (10.1016/j.ijrobp.2012.01.094)
2010
- Evans, M. and Powell, N. G. 2010. The changing aetiology of head and neck cancer: the role of human papillomavirus. Clinical Oncology 22(7), pp. 538-546. (10.1016/j.clon.2010.05.024)
2008
- Thomas, K. J.et al. 2008. HPV16 E629-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function. International Journal of Cancer 122(12), pp. 2791-2799. (10.1002/ijc.23475)
2001
- Evans, M.et al. 2001. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6. The Journal of Immunology 167(9), pp. 5420-5428.